title: Obesity and colorectal cancer risk: a meta-analysis of cohort studies.
abstract: OBJECTIVE
  To evaluate the association between obesity and colorectal cancer risk.
  
  
  METHODS
  We searched PubMed, EMBASE, and the Cochrane Library up to January 1, 2007. Cohort studies permitting the assessment of causal association between obesity and colorectal cancer, with clear definition of obesity and well-defined outcome of colorectal cancer were eligible. Study design, sample size at baseline, mean follow-up time, co-activators and study results were extracted. Pooled standardized effect sizes were calculated.
  
  
  RESULTS
  The pooled relative risk (RR) of colorectal cancer was 1.37 (95% CI: 1.21-1.56) for overweight and obese men, 1.07 (95% CI: 0.97-1.18) for women measured by body mass index (BMI). The pooled RR for the highest vs the lowest quantiles of BMI was 1.59 (95% CI: 1.35-1.86) for men and 1.22 (95% CI: 1.08-1.39) for women at risk of colon cancer, 1.16 (95% CI: 0.93-1.46) for men and 1.23 (95% CI: 0.98-1.54) for women at risk of rectal cancer. The pooled RR for the highest vs the lowest quantiles of waist circumference was 1.68 (95% CI: 1.36-2.08) for men and 1.48 (95% CI: 1.19-1.84) for women at risk of colon cancer, 1.26 (95% CI: 0.90-1.77) for men and 1.23 (95% CI: 0.81-1.86) for women at risk of rectal cancer. The pooled RR for the highest quantiles vs the lowest quantiles of waist-to-hip ratio was 1.91 (95% CI: 1.46-2.49) for men and 1.49 (95% CI 1.23-1.81) for women at risk of colon cancer, 1.93 (95% CI: 1.19-3.13) for men and 1.20 (95% CI: 0.81-1.78) for women at risk of rectal cancer. Compared with 'normal range', the pooled RR for proximal colon cancer was 1.14 (95% CI: 0.88-1.47) for the overweight and 1.41 (95% CI: 0.66-3.01) for the obese. The pooled RR for the highest quantiles vs the lowest quantiles was 2.05 (95% CI: 1.23-3.41) with waist circumference, 1.66 (95% CI: 0.69-3.99) with waist-to-hip ratio. Compared with 'normal range', the pooled RR for distal colon cancer was 1.38 (95% CI: 1.02-1.87) for the overweight and 1.23 (95% CI: 0.80-1.90) for the obese. The pooled RR for the highest quantiles vs the lowest quantiles was 1.86 (95% CI: 1.05-3.30) with waist circumference, and 1.79 (95% CI: 0.82-3.90) with waist-to-hip ratio.
  
  
  CONCLUSIONS
  Obesity is a statistically significant risk factor for colorectal cancer and the relationship is more significant in men than in women among different cancer subsites. Indexes of abdominal obesity are more sensitive than those of overall obesity.
authors: Department of Endocrinology, Zhongnan Hospital, Wuhan University, Wuhan 430071, Hubei Province, China.
authors: Zhe
authors: Z
authors: Dai
authors: Yan-Cheng
authors: YC
authors: Xu
authors: Li
authors: L
authors: Niu
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015992:Body Mass Index; D015331:Cohort Studies; D015179:Colorectal Neoplasms / Q000453:epidemiology* / Q000209:etiology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009765:Obesity; D012307:Risk Factors; D049629:Waist-Hip Ratio
references: Am J Physiol Gastrointest Liver Physiol. 2007 Mar;292(3):G923-9
references: 17170030
references: Cancer Causes Control. 2006 Apr;17(3):239-49
references: 16489531
references: Am J Gastroenterol. 2001 Jul;96(7):2238-46
references: 11467659
references: Int J Cancer. 2007 May 1;120(9):2007-12
references: 17266031
references: Ann Epidemiol. 1996 Jul;6(4):276-82
references: 8876837
references: Cancer Sci. 2006 Oct;97(10):1099-104
references: 16918995
references: J Natl Cancer Inst. 2005 Nov 16;97(22):1688-94
references: 16288122
references: Int J Cancer. 2006 Mar 15;118(6):1496-500
references: 16187280
references: Br J Cancer. 2001 Aug 3;85(3):346-9
references: 11487263
references: Nat Clin Pract Gastroenterol Hepatol. 2007 Mar;4(3):118-9
references: 17339849
references: Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):553-9
references: 15066919
references: Cancer Causes Control. 2003 Feb;14(1):75-84
references: 12708728
references: Dig Liver Dis. 2006 Sep;38(9):668-72
references: 16790371
references: Cancer Causes Control. 1994 Jan;5(1):38-52
references: 8123778
references: Int J Obes Relat Metab Disord. 1998 Feb;22(2):178-84
references: 9504326
references: Am J Epidemiol. 1999 Aug 15;150(4):390-8
references: 10453815
references: J Natl Cancer Inst. 1997 Jul 2;89(13):948-55
references: 9214674
references: Public Health Nutr. 2004 Feb;7(1A):187-200
references: 14972060
references: Eur J Cancer. 2006 Jan;42(1):84-90
references: 16321519
references: Int J Obes Relat Metab Disord. 2004 Apr;28(4):559-67
references: 14770200
references: Cancer Causes Control. 1995 Mar;6(2):164-79
references: 7749056
references: Gut. 2002 Aug;51(2):191-4
references: 12117878
references: Ann Intern Med. 1995 Mar 1;122(5):327-34
references: 7847643
references: Br J Cancer. 2005 Oct 31;93(9):1062-7
references: 16234822
references: Int J Cancer. 2006 Jan 15;118(2):458-66
references: 16049963
references: Eur J Cancer. 2006 Oct;42(15):2590-7
references: 16914307
references: Eur J Cancer. 2001 Oct;37 Suppl 8:S4-66
references: 11602373
references: Important Adv Oncol. 1996;:123-37
references: 8791132
references: J Natl Cancer Inst. 2006 Jul 5;98 (13):920-31
references: 16818856
references: Hum Pathol. 2007 Jun;38(6):842-9
references: 17350669
references: Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1204-11
references: 15894673
references: Cancer Causes Control. 2004 Aug;15(6):581-9
references: 15280637
references: Gut. 2006 Jan;55(1):62-7
references: 15972299